Bar-Shalom R - Search Results

1

Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O. Bar-Shalom R, et al. J Nucl Med. 2003 Aug;44(8):1200-9. J Nucl Med. 2003. PMID: 12902408 Free article. Clinical Trial.

2

Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG.

Israel O, Mor M, Gaitini D, Keidar Z, Guralnik L, Engel A, Frenkel A, Bar-Shalom R, Kuten A. Israel O, et al. J Nucl Med. 2002 Sep;43(9):1129-36. J Nucl Med. 2002. PMID: 12215549 Free article.

3

Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.

Israel O, Mekel M, Bar-Shalom R, Epelbaum R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M, Gaitini D. Israel O, et al. J Nucl Med. 2002 Oct;43(10):1295-303. J Nucl Med. 2002. PMID: 12368366 Free article.

4

Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study.

Bar-Shalom R, Yefremov N, Haim N, Dann EJ, Epelbaum R, Keidar Z, Gaitini D, Frenkel A, Israel O. Bar-Shalom R, et al. Radiology. 2003 May;227(2):353-60. doi: 10.1148/radiol.2272020195. Epub 2003 Mar 13. Radiology. 2003. PMID: 12637679

5

PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft.

Keidar Z, Engel A, Nitecki S, Bar Shalom R, Hoffman A, Israel O. Keidar Z, et al. Mol Imaging Biol. 2003 Jan-Feb;5(1):23-5. doi: 10.1016/s1536-1632(03)00035-0. Mol Imaging Biol. 2003. PMID: 14499158

6

Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT.

Bar-Shalom R, Gaitini D, Keidar Z, Israel O. Bar-Shalom R, et al. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. doi: 10.1007/s00259-004-1506-0. Epub 2004 Mar 9. Eur J Nucl Med Mol Imaging. 2004. PMID: 15007566 Clinical Trial.

7

Positron emission tomography in the evaluation of lymphoma.

Israel O, Keidar Z, Bar-Shalom R. Israel O, et al. Semin Nucl Med. 2004 Jul;34(3):166-79. doi: 10.1053/j.semnuclmed.2004.03.002. Semin Nucl Med. 2004. PMID: 15202099 Review.

8

PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.

Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, Israel O. Keidar Z, et al. J Nucl Med. 2004 Oct;45(10):1640-6. J Nucl Med. 2004. PMID: 15471827 Free article.

9

Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?

Israel O, Mor M, Guralnik L, Hermoni N, Gaitini D, Bar-Shalom R, Keidar Z, Epelbaum R. Israel O, et al. J Nucl Med. 2004 Dec;45(12):2045-51. J Nucl Med. 2004. PMID: 15585480 Free article.

10

The diabetic foot: initial experience with 18F-FDG PET/CT.

Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O. Keidar Z, et al. J Nucl Med. 2005 Mar;46(3):444-9. J Nucl Med. 2005. PMID: 15750157 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters